Skip to main content

Recent News

FDA has approved Otulfi (ustekinumab-aauz), a ustekinumab biosimilar for the treatment of Crohn’s disease, ulcerative colitis, moderate to severe plaque psoriasis and active psoriatic arthritis. Otulfi ismade by Fresenius Kabi and Formycon https://t.co/p2h9X0C16W https://t.co/YD0uJSEbaq
Dr. John Cush @RheumNow (  View Tweet)
JAMA metaanalysis of psoriasis pts (40 RCTs, 21 438 pts) Rx w/ biologics: a >=90% PASI (skin) response was less likely with older age, prior biologics, higher BMI, and smoking https://t.co/v5EpOpYVYt https://t.co/wXTXP76Emu
Dr. John Cush @RheumNow (  View Tweet)
Hand-Held Imaging Could Transform Arthritis Care A new hand-held scanner developed by UCL researchers can generate highly detailed 3D photoacoustic images in just seconds, paving the way for their use in a clinical setting for the first time and offering the potential for… https://t.co/YSCfoWCXpr https://t.co/du6cruFfRQ
Dr. John Cush @RheumNow (  View Tweet)
RheumNow Live 2025: Redefining Rheumatology Practice Join the Revolution in Rheumatology Education! Welcome to RheumNow Live 2025, where the brightest minds in rheumatology converge to push the boundaries of what's possible. This year's conference is set to be our most… https://t.co/9FwdR1fQoC https://t.co/v1j8tQE7S6
Dr. John Cush @RheumNow (  View Tweet)
2023 EULAR Recommendations on Management of Fatigue A 2023 EULAR task force has made recommendations to the approach and management of fatigue in patients with inflammatory rheumatic and musculoskeletal diseases (I-RMDs). https://t.co/t74IKmead2 https://t.co/imoJ5DbaYe
Dr. John Cush @RheumNow (  View Tweet)
VASCULTIS Literature analysis shows most frequent citations, research centers and reveals the top 3 vasculitis topics to be: 1. Immune checkpoint inhibitors 2. GPA/Wegener's granulomatosis 3. SLE - lupus vasculopathy https://t.co/FS2cuv9gt4 https://t.co/ziI4sfexrm
Dr. John Cush @RheumNow (  View Tweet)

Risk of Uveitis with Spondyloarthritis

A retrospective registry study shows that uveitis may be seen in 10% with the diagnosis of axial spondyloarthritis (axSpA) but becomes more common (47%) over the next 30 years of disease. The good news is that biologic therapy can significantly lower the risk of uveitis in (SpA).

Read Article

Long Term Antibiotics Increase Risk of RA

JAMA has published a population-based retrospective cohort study showing a possible association between the long-term use of antibiotics and the risk of rheumatoid arthritis (RA).

Read Article
Using MRI to Evaluate Knee Pain Interim results from a randomized trial show that middle-aged patients with knee pain and suspected meniscal tears can benefit from MRI scans even in relatively simple cases. https://t.co/xAVA07LcqD https://t.co/YRrZgiMQjs
Dr. John Cush @RheumNow (  View Tweet)
A review of two physician case reports. These cases are patients who presented with severe active manifestations of granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA). https://t.co/Gm9RE0IEJr https://t.co/YbUjBYE016
Dr. John Cush @RheumNow (  View Tweet)
A randomized, controlled study of whole-body electromyostimulation (strength training) in 72 overweight symptomatic knee OA pts Rx w/ usual care vs WB-EMS (3x q 14d) for 7 mos. WB-EMS had signif improved knee pain (KOOS),(-9.0 points, p 0.004) & function https://t.co/UWs3YgYB9F https://t.co/odwsd4AuCh
Dr. John Cush @RheumNow (  View Tweet)
Medscapes Diagnostic evaluation of inflammatory myositis patients Labs Imaging EMG/NCV Muscle Bx https://t.co/q7q9m9uEk5 https://t.co/c6SMBxcLBW
Dr. John Cush @RheumNow (  View Tweet)
Medical Expenditure Panel Survey study (2018 to 2020) identified 4.27 million adults with RA and found significantly higher (mean $3,382) health care expenditures, particularly prescription medication costs, and was associated with suboptimal quality of life… https://t.co/87os1PWT2F https://t.co/znmkucBIdE
Dr. John Cush @RheumNow (  View Tweet)
Korean population study shows RA was linked to a higher migraine risk, regardless of seropositivity. Comparison of 42,644 RA vs 213,370 controls - found higher risk of migraine (adj HR 1.21; 1.17–1.26). https://t.co/i3ggZ356Qh https://t.co/jveLGUZk4i
Dr. John Cush @RheumNow (  View Tweet)

Hand-Held Imaging Could Transform Arthritis Care

EurekAlert!

A new hand-held scanner developed by UCL researchers can generate highly detailed 3D photoacoustic images in just seconds, paving the way for their use in a clinical setting for the first time and offering the potential for earlier disease diagnosis.

Read Article
Taiwan claims data study compared (2003-2013) 30,911 newly diagnosed #AS pts to 309,110 controls found significantly higher risk of motor vehicle accidents w/ injuries in AS, esp. 2yrs after Dx (IRR 2.0) https://t.co/Ca0LN675oj https://t.co/UKQMgQYMAL
Dr. John Cush @RheumNow (  View Tweet)
Full read review of Pathogenic autoantibodies in idiopathic inflammatory myopathies: antisynthetase autoAbs, TIF1, MDA5, SRP, HMGCR, TRIM72, cN1A, FHL1, eIF3 autoantibodies and more https://t.co/DSov27xdrT https://t.co/58wKHGMneH
Dr. John Cush @RheumNow (  View Tweet)
Study of oral microbiota & psoriasis (72 PSO vs 16 healthy controls) - 16S rRNA gene sequencing of saliva found (in PSO) signif incrCapnocytandophaga, Campylobacter, Acetobacter, but decr Bacteroides, Muribaculaceae. PSA pts incr Aggregatibacter, but decr Prevotella… https://t.co/GukbWkl1Gz https://t.co/HgLcD6bP2I
Dr. John Cush @RheumNow (  View Tweet)
ASAS Imaging Recommendations for Suspected Spondyloarthritis ASAS (Assessment of Spondyloarthritis International Society) has convened specialized task force to guide imaging request on patients with suspected/known axial spondyloarthritis (axSpA). https://t.co/C95jGH2LLK https://t.co/FSYrtqDNn1
Dr. John Cush @RheumNow (  View Tweet)
Declining Menopausal Hormone Therapy in Postmenopausal Women A two decade cross-sectional population study has shown a marked downward trend in menopausal hormone therapy (MHT), with an over 80% reduction, especially in women aged 52 - 65 years. https://t.co/yKPGTOAFvQ https://t.co/72etpOVrSO
Dr. John Cush @RheumNow (  View Tweet)